| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
RESEARCH |
Departments of Physiology and Pharmacology, and Obstetrics and Gynaecology, University of Western Ontario, London, Ontario, Canada, N6A 5C1
Correspondence should be addressed to Thomas G Kennedy; Email: tom.kennedy{at}fmd.uwo.ca
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
Through the use of mRNA differential display (ddRT-PCR), we exploited both the tight hormonal control for the onset of uterine receptivity and an established model for the induction of a sensitized endometrium in ovariectomized, hormone-treated rats (De Feo 1963, Psychoyos 1973, Kennedy & Ross 1997), and identified vitamin D3 upregulated protein 1 (Vdup1) as a gene upregulated in the nonsensitized rat endometrium. This was the case for both the refractory endometrium (the endometrial state immediately following receptivity) and during a model of delayed implantation, the prereceptive state that supports the survival of an embryo in diapause until sensitization is achieved. VDUP1 has been shown to interact with thioredoxin (TXN) by binding to its active site and inhibiting its biologic action (Nishiyama et al. 1999, Junn et al. 2000, Yamanaka et al. 2000). TXN has been implicated in numerous cellular processes, including the promotion of cell proliferation, the inhibition of apoptosis and the regulation of transcription factor binding and antioxidant activity (reviewed in Nishiyama et al. 2001). In addition, TXN is highly expressed in the uterus of mice (Osborne et al. 2001), rats (Sahlin et al. 1997) and humans (Perkins et al. 1995), as well as in the highly invasive cytotrophoblast cells of the human placenta (Perkins et al. 1995). We show that Txn mRNA levels increase within the decidualizing endometrium, in contrast to Vdup1. The spatial and temporal expression for Vdup1 and Txn mRNA presented in the current study, and the opposing actions of these molecules reported in the literature, suggest that these molecules may interact within the endometrial stroma to modulate the potential for the decidual response in the rat.
| Materials and Methods |
|---|
|
|
|---|
Identification of Vdup1 by differential display
Changes in endometrial gene expression in endometrium differentially sensitized for decidualization were analyzed by the method of ddRT-PCR as described by Liang and Pardee (1992) and modified by Simmons and Kennedy (2000). In summary, following separation of endometrium from myometrium, it was immediately homogenized in guanidinium isothiocyanate buffer, and total RNA was extracted (Chomczynski & Sacchi 1987). After DNAse I (Gibco-BRL, Burlington, ON, Canada) treatment, total RNA was reversed transcribed using the degenerate 3' primer T11MC, where M is either C, G, T or A. PCR reactions were then performed using the same 3' primer and the 5' primer GATCTGACAC in the presence of [
-35S]dATP (Bauer et al. 1993). The PCR products were run on standard 6% (w/v) polyacrylamide-urea sequencing gels, transferred to filter paper, dried and exposed to radiograph film. After development of the film, the apparently differentially expressed cDNA band was cut out of the dried gel, rehydrated, precipitated and then reamplified using the same PCR conditions as for differential display, except that dNTP concentrations were 10-fold higher and [
-35S]dATP was not present. Half of the reamplification products were run in a 1.5% (w/v) agarose gel and stained with ethidium bromide for visualization; the remainder was kept for cloning into the pGEM T-easy vector (Promega). Sequencing was performed using an automated fluorescent DNA sequencer (John P. Robarts Research Institute DNA Sequencing Facility, London, ON, Canada).
northern blot analysis
An amount of 10 µg of total RNA was denatured and subjected to electrophoresis in a denaturing gel as previously described (Sambrook et al. 1989). RNA was then transferred to Hybond-N membrane (Amersham) by capillary transfer and cross-linked by exposure to 1.2 x 105 µJ/cm2 of UV energy (Hoefer Pharmacia Biotech, San Francisco, CA, USA). northern blot analysis was performed as described by Church and Gilbert (1984), with some modifications. Briefly, membranes were prehybridized in Church buffer (7% (w/v) SDS, 0.25 mol Na2HPO4/l (pH 7.2), 1 mmol EDTA/l and 1% (w/v) BSA) at 65 ºC for at least 30 min. The cDNA amplicon isolated from the ddRT-PCR gel was used as a template to synthesize 32P-labeled DNA probes for northern blot hybridization. An amount of 25 ng of cDNA was labeled by the random-priming technique in the presence of [
-32P]dCTP (Amersham) with an oligo-labeling kit (Random Primers Labeling System; Gibco-BRL). Hybridizations were carried out at 60 ºC for 20 h. The membranes were subsequently washed three times (15 min each) at 65 ºC in 20 mmol Na2HPO4/l (pH 7.2), with 4% (w/v) SDS and subjected to autoradiography at -70 ºC with a Biomax MS TranScreen-HE intensifying screen (Eastman Kodak) for the appropriate exposure time. Blots were then stripped in 1 mmol Tris/l, 1 mmol EDTA/l and 0.1 x Denhardts reagent (1 x Denhardts: 2% (w/v) BSA, 2% (w/v) Ficoll and 2% (w/v) polyvinylpyrrolidone, pH 8.0) for 2 h at 75 ºC, and sequentially reprobed with radiolabeled cDNAs for Txn, thioredoxin reductase 1 (Txnrd1) and 18S rRNA. The autoradiographs were digitized using a Hewlett Packard Scanjet 4c/T scanner, and the densitometric intensity of each signal was quantified with Pharmacia ImageMaster VDS Video Documentation System Software, Version 2.0. The 18S rRNA signal was used to determine the relative amounts of RNA loaded into each well and transferred to the membrane and to normalize Vdup1, Txn and Txnrd1 signals (Smith & Hammond 1991).
In situ hybridization
At the time total RNA was isolated for the ddRT-PCR and northern blot analyses, some uterine horns were fixed by immersion in 4% (w/v) paraformaldehyde for 24 h. The horns were then rinsed in two changes of PBS and stored in 70% (v/v) ethanol until embedded in paraffin and sectioned at 6 µm.
The vector, containing an amplicon cloned from the differential display experiments, was linearized and cRNA sense and antisense probes were synthesized in the presence of digoxigenin (DIG)-labeled rUTP (Roche Molecular Biochemicals, Laval, QC, Canada) according to the manufacturers instructions. The in situ hybridization technique used has been described in detail previously (Harvey et al. 1995). Briefly, uterine cross-sections were dewaxed in xylene, rehydrated through an alcohol series to 2 x SSC, digested in proteinase K at 37 ºC for 57.5 min, and acetylated by incubation with freshly prepared 0.1 mol triethanolamine/l and 0.56% (v/v) acetic anhydride at room temperature. After prehybridization at 50 ºC for 4 h in a 50% (v/v) formamide, 5 x SSPE, 1 x Denhardts solution, the sections were hybridized with 100 ng of cRNA probe and 400 ng of tRNA (in prehybridization solution) under a cover slip for 20 h at 50 ºC in a sealed humidified chamber. The sections were then washed extensively, treated with RNase and processed for immunologic detection of the DIG-labeled cRNA probe using anti-DIG antibodies at a dilution of 1:500 (Roche Molecular Biochemicals). Color development was allowed to continue until a signal (blue-purple precipitate) was detected. The color reaction for the sense cRNA-treated slides was terminated at the same time as for the antisense slides. Sections were then mounted using GVA-mount (Zymed Laboratories, San Francisco, CA, USA).
Statistical analysis
Experiments quantifying changes in mRNA levels by northern blot analysis were performed three times on separate groups of ovariectomized, hormone-treated rats (except when stated otherwise). The data were analyzed by within-blocks ANOVA, with experiments being considered blocks. Duncans multiple range test was performed to determine differences between groups. P < 0.05 was considered significant.
| Results |
|---|
|
|
|---|
|
|
|
|
|
| Discussion |
|---|
|
|
|---|
Vdup1 was originally discovered as a gene upregulated during 1,25-dihydroxyvitamin D3-induced differentiation of HL-60 cells (Chen & DeLuca 1994) and downregulated in N-methyl-N-nitrosourea-induced mammary tumors (Young et al. 1996), suggesting that VDUP1 may be involved in the regulation of cell growth and tumor suppression. The inference that VDUP1 functions as a negative regulator of cell growth and in tumor suppression has gained support recently, as a number of studies have shown a decrease in Vdup1 gene expression associated with the onset of various cancers, including breast (Butler et al. 2002), colon (Butler et al. 2002, Ikarashi et al. 2002) and B-cell lymphoma (de Vos et al. 2003). In addition, some studies have shown that an increase in VDUP1 protects against cancer and inhibits tumor cell growth (Butler et al. 2002, Goldberg et al. 2003, Han et al. 2003).
VDUP1 has also been implicated as a binding protein for the redox regulator TXN, binding to its active site and inhibiting its biologic activity (Nishiyama et al. 1999, Junn et al. 2000, Yamanaka et al. 2000). TXN has been shown to have a wide range of biologic activities, including growth promotion and proliferation, antioxidant activity, regulation of transcription factor binding and inhibition of apoptosis (reviewed in Nishiyama et al. 2001). It is possible that the growth inhibition effects of VDUP1 are mediated through TXN inhibition. In fact, Schulze et al.(2002) recently described a system in which VDUP1 and TXN have opposing effects on human aortic smooth muscle cell proliferation. Specifically, overexpression of VDUP1 inhibited cell proliferation, in contrast to TXN-stimulated cell proliferation, as well as prevented nuclear translocation of TXN in response to platelet-derived growth factor, a potent stimulator of aortic smooth muscle cell proliferation and TXN activity (Schulze et al. 2002).
Because VDUP1 has been shown to regulate cell proliferation and growth negatively through inhibition of TXN activity, and because TXN has been shown to be highly expressed in the uterus of mice (Osborne et al. 2001) and humans (Perkins et al. 1995), as well as in the highly invasive cytotrophoblast cells of the human placenta (Perkins et al. 1995), we investigated whether Txn mRNA levels would have an opposite expression pattern to that of Vdup1 in the rat endometrium. Indeed, Txn mRNA levels increased within the decidualizing endometrium but remained low within the nondecidualizing, refractory endometrium (Fig. 3
). While Vdup1 and Txn mRNA levels within the endometrium appear to have opposing expression patterns, they are both induced in the endometrial stroma (Fig. 4
). This converse temporal expression but shared spatial expression suggests that they may have linked, but opposing roles in stromal cell proliferation within the uterus, with TXN stimulating the proliferation of decidual cells and VDUP1 inhibiting cell proliferation in the refractory or nonsensitized endometrial stromal compartment.
In addition to verifying the results obtained by ddRT-PCR, northern blot analysis also revealed a statistically significant increase in Vdup1 mRNA levels within the endometrium of animals in the day 5, low E2 group (low E2 group, Fig. 2
). These animals, although temporally correct for sensitization (equivalent of day 5 of pseudopregnancy), were hormonally nonsensitized, as they did not receive E2 on the evening of day 4 but only an injection of P4. By contrast, rats with nonsensitized endometrium on day 5, as a consequence of a high dose of E2 on the evening of day 4, had low levels of Vdup1 mRNA (high E2 group, Fig. 2
). These data would indicate that prolonged P4 exposure in the absence of E2, a situation that simulates lactational delay of sensitization/receptivity, results in an increase in Vdup1 mRNA levels. To investigate this observation further, we used a model of delayed implantation. Ovariectomized rats were given 96 h of P4 treatment (after 48 h of P4 priming, further P4 treatment in the absence of E2 results in a delayed endometrium that will become sensitized only after E2 exposure) followed by either more P4 (delayed) or P4 plus E2 (sensitized). High levels of Vdup1 mRNA were evident within the uteri of delayed animals, whereas low levels of Vdup1 mRNA were seen in the sensitized animals following the termination of delay (Fig. 5A and B
). The fact that Vdup1 mRNA is upregu lated within the endometrium during delayed implantation further supports the hypothesis that VDUP1 may help to maintain a quiescent, nondecidualizing stromal cell population. In addition, E2 administration, which is itself a known promoter of cell growth, is sufficient significantly to downregulate Vdup1 mRNA levels within the uteri of ovariectomized animals (Fig. 5C and D
). The absence of an E2-induced increase in Txn mRNA (Fig. 5C and D
) was unexpected, as Sahlin et al.(1997) showed an increase in Txn mRNA within the rat uterus in response to E2, although this could be due to the fact that in their study 2.5 µg of E2 was injected, whereas we used only 1.0 µg. We did see, however, a significant increase in Txnrd1 mRNA levels in response to 1.0 µg of E2 (Fig. 5C and D
). TXNRD1 is a protein that reduces the oxidized, inactive form of TXN back to its active state (Holmgren & Bjornstedt 1995). Presumably, an increase in Txnrd1 expression would translate into an increase in Txn activity within the cell. Together these data indicate that E2 decreases Vdup1 mRNA levels and possibly increases TXN activity through decreased TXN inhibition and increased TXN recycling, while P4 prevents the E2-induced changes in gene expression. P4 alone does not induce an increase in Vdup1 mRNA levels, but, rather, a prolonged exposure to P4, as in the case of delayed implantation, is required (Fig. 5A and B
).
The expression patterns of Vdup1 and Txn mRNA within the rat uterus presented in the current study, along with the established interaction of these proteins to regulate cell proliferation in other systems, positions these molecules as potential regulators of cell proliferation in the rat uterus around the time of embryo implantation. While the function of VDUP1 in the nonsensitized endometrium is probably the inhibition of TXN, this has yet to be established experimentally. Other TXN-independent functions may exist for VDUP1. In fact, a recent study by Han et al.(2003) showed that VDUP1 induced cell-cycle arrest and physically interacted with transcriptional core-pressors, presumably inhibiting cell growth in a TXN-independent fashion. Clearly, more work is needed to clarify the function of VDUP1 within the endometrium during the peri-implantation period.
| Acknowledgements |
|---|
|
|
|---|
| Footnotes |
|---|
D G Simmons is currently at Genes and Development Research Group, Department of Biochemistry and Molecular Biology, University of Calgary, Calgary, Alberta, Canada, T2N 4N1
| References |
|---|
|
|
|---|
Bauer D, Muller H, Reich J, Riedel H, Ahrenkiel V, Warthoe P & Strauss M 1993 Identification of differentially expressed mRNA species by an improved display technique (DDRT-PCR). Nucleic Acids Research 21 42724280.
Butler LM, Zhou X, Xu WS, Scher HI, Rifkind RA, Marks PA & Richon VM 2002 The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin. PNAS 99 1170011705.
Chen KS & DeLuca HF 1994 Isolation and characterization of a novel cDNA from HL-60 cells treated with 1,25-dihydroxyvitamin D-3. Biochimica et Biophysica Acta 1219 2632.[Medline]
Chomczynski P & Sacchi N 1987 Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analytical Biochemistry 162 156159.[ISI][Medline]
Church GM & Gilbert W 1984 Genomic sequencing. PNAS 81 19911995.
De Feo VJ 1963 Determination of the sensitive period for the induction of the deciduomata in the rat by different inducing procedures. Endocrinology 73 488497.
Fawcett DW 1950 The development of the mouse ova under the capsule of the kidney. Anatomical Record 108 7191.
Finn CA & Keen P 1963 The induction of deciduomata in the rat. Journal of Embryology and Experimental Morphology 11 673682.
Goldberg SF, Miele ME, Hatta N, Takata M, Paquette-Straub C, Freedman LP & Welch DR 2003 Melanoma metastasis suppression by chromosome 6: evidence for a pathway regulated by CRSP3 and TXNIP. Cancer Research 63 432440.
Han SH, Jeon JH, Ju HR, Jung U, Kim KY, Yoo HS, Lee YH, Song KS, Hwang HM, Na YS, Yang Y, Lee KN & Choi I 2003 VDUP1 upregulated by TGF-ß1 and 1,25-dihydroxyvitamin D3 inhibits tumor cell growth by blocking cell-cycle progression. Oncogene 22 40354046.[CrossRef][ISI][Medline]
Harvey MB, Leco KJ, Arcellana-Panlilio MY, Zhang X, Edwards DR & Schultz GA 1995 Proteinase expression in early mouse embryos is regulated by leukaemia inhibitory factor and epidermal growth factor. Development 121 10051014.[Abstract]
Holmgren A & Bjornstedt M 1995 Thioredoxin and thioredoxin reductase. Methods in Enzymology 252 199208.[CrossRef][ISI][Medline]
Ikarashi M, Takahashi Y, Ishii Y, Nagata T, Asai S & Ishikawa K 2002 Vitamin D3 up-regulated protein 1 (VDUP1) expression in gastrointestinal cancer and its relation to stage of disease. Anticancer Research 22 40454048.[ISI][Medline]
Junn E, Han SH, Im JY, Yang Y, Cho EW, Um HD, Kim DK, Lee KW, Han PL, Rhee SG & Choi I 2000 Vitamin D3 up-regulated protein 1 mediates oxidative stress via suppressing the thioredoxin function. Journal of Immunology 164 62876295.
Kennedy TG & Ross HE 1997 Temporal- and hormone-dependent changes in uterine sensitization for the decidual cell reaction and decidualization in vitro of rat endometrial stromal cells. Journal of Reproduction and Fertility 109 129136.[Abstract]
Kirby DR 1963 The development of mouse blastocysts transplanted to the scrotal and cryptorchid testis. Journal of Anatomy 97 119130.
Kirby DR 1965 The invasiveness of the trophoblast. In The Early Conceptus, Normal and Abnormal, pp 6874. Ed. WW Park. Edinburgh: University of St Andrews Press.
Liang P & Pardee AB 1992 Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 257 967971.
Martel D & Psychoyos A 1978 Progesterone-induced oestrogen receptors in the rat uterus. Journal of Endocrinology 76 145154.[Abstract]
Nishiyama A, Matsui M, Iwata S, Hirota K, Masutani H, Nakamura H, Takagi Y, Sono H, Gon Y & Yodoi J 1999 Identification of thioredoxin-binding protein-2/vitamin D3 up-regulated protein 1 as a negative regulator of thioredoxin function and expression. Journal of Biological Chemistry 274 2164521650.
Nishiyama A, Masutani H, Nakamura H, Nishinaka Y & Yodoi J 2001 Redox regulation by thioredoxin and thioredoxin-binding proteins. IUBMB Life 52 2933.[ISI][Medline]
Osborne LJ, Tonissen KF, Tang VH & Clarke FM 2001 Expression and localisation of thioredoxin in mouse reproductive tissues during the oestrous cycle. Molecular Reproduction and Development 58 359367.[CrossRef][ISI][Medline]
Perkins AV, Di Trapani G, McKay MS & Clarke FM 1995 Immuno-cytochemical localization of thioredoxin in human trophoblast and decidua. Placenta 16 635642.[CrossRef][ISI][Medline]
Psychoyos A 1973 Endocrine control of egg implantation. In Handbook of Physiology, pp 187215. Eds RO Greep, EB Astwood & SR Geiger. Washington, DC: American Physiological Society.
Sahlin L, Holmgren A & Eriksson H 1997 Thioredoxin messenger ribonucleic acid is regulated by estradiol in the rat uterus. Biology of Reproduction 57 10561059.[Abstract]
Sambrook K, Fritsch E & Maniatis T 1989 Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Press.
Schulze PC, De Keulenaer GW, Yoshioka J, Kassik KA & Lee RT 2002 Vitamin D3-upregulated protein-1 (VDUP-1) regulates redox-dependent vascular smooth muscle cell proliferation through interaction with thioredoxin. Circulation Research 91 689695.
Simmons DG & Kennedy TG 2000 Induction of glucose-regulated protein 78 in rat uterine glandular epithelium during uterine sensitization for the decidual cell reaction. Biology of Reproduction 62 11681176.
Smith CL & Hammond GL 1991 Ontogeny of corticosteroid-binding globulin biosynthesis in the rat. Endocrinology 128 983988.[Abstract]
de Vos S, Hofmann WK, Grogan TM, Krug U, Schrage M, Miller TP, Braun JG, Wachsman W, Koeffler HP & Said JW 2003 Gene expression profile of serial samples of transformed B-cell lymphomas. Laboratory Investigation 83 271285.[ISI][Medline]
Yamanaka H, Maehira F, Oshiro M, Asato T, Yanagawa Y, Takei H & Nakashima Y 2000 A possible interaction of thioredoxin with VDUP1 in HeLa cells detected in a yeast two-hybrid system. Biochemical and Biophysical Research Communications 271 796800.[CrossRef][ISI][Medline]
Yochim JM & De Feo VJ 1963 Hormonal control of the onset, magnitude and duration of uterine sensitivity in the rat by steroid hormones of the ovary. Endocrinology 72 317326.
Young LH, Yang X & Voigt JM 1996 Alteration of gene expression in rat mammary tumors induced by N-methyl-N-nitrosourea. Molecular Carcinogenesis 15 251260.[CrossRef][ISI][Medline]
This article has been cited by other articles:
![]() |
H.-F. Xia, J. Sun, Q.-H. Sun, Y. Yang, and J.-P. Peng Implantation-associated gene-1 (Iag-1): a novel gene involved in the early process of embryonic implantation in rat Hum. Reprod., July 1, 2008; 23(7): 1581 - 1593. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |